Financial disclosure by clinical investigators (21 C.F.R, Part 54).

[摘要] Part 54 of Title 21 of the Federal Code of Regulations defines the financial disclosure by clinical investigators in terms of administrative procedures regarding the clinical studies aimed to determine whether the applications are approvable under the statutory requirement (also for biological products and including the potential increase in the value of the interest if a specific product is approved).

[发布日期] 2016-01-01

[学科分类] 食品科学和技术

[关键词] Food quality control/food safety;Legal proceedings/administrative proceedings;Inspection;Authorization/permit